New patent for Chemocentryx drug TAVNEOS

April 22, 2023 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are two patents protecting…

The post New patent for Chemocentryx drug TAVNEOS appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.